Control Bionics News
Our latest news
NeuroNode is now an Apple-Approved Assistive Tech Device
Control Bionics is excited to announce that NeuroNode® has been listed as a third-party assistive technology device on Apple’s website. Apple’s inclusion of the NeuroNode in its Apple-approved assistive technologies underscores NeuroNode’s versatility and...
Control Bionics partners with Double R&D to launch NeuroNode Technology in Japan
Control Bionics (ASX:CBL) is all set to launch its NeuroNode Trilogy technology in Japan in partnership with major assistive technology distributor, Double R&D Co Ltd.
Walk Through Grid 3’s Powerful New Updates with Nancy Inman and Belva Holman
We interviewed Nancy Inman and Belva Holman about the powerful new updates to WordPower 100 in Grid 3. Watch the interview.
2022: A Look at Key Priorities for Control Bionics
Highlighted in an article by Kalkine Media, Control Bionics achieved a year of strong growth and is forging ahead in the current year to level up its momentum.
![[Free Download] AAC Implementation Plan Worksheet](https://controlbionics.com/wp-content/uploads/2021/11/Implementation-Plan-400x250.png)
[Free Download] AAC Implementation Plan Worksheet
It’s hard to get parents and teachers to stick to your AAC implementation plan. Download our free template and get tips for adherence.
Share Your Colours: Rare Disease Day 2022
Control Bionics is proud to help people all over the world living with rare diseases on Rare Disease Day 2022, and every day.
Combination is Key: New Research Paper Confirms Eye Gaze and EMG Switching Outperforms Traditional Methods
According to the recent paper published by biomedical engineering student Lester Lo at RMIT University, eye gaze combined with EMG switching outperformed traditional eye gaze AAC systems.